The Incidence and Prevalence of Crude and Familial Multiple Sclerosis in Tehran, Iran in 2021

The Incidence and Prevalence of Crude and Familial Multiple Sclerosis in Tehran, Iran in 2021 Publisher Pubmed

Ezabadi SG¹ ; Ayoubi S¹ ; Sahraian MA¹ ; Omrani MA¹ ; Eskandarieh S¹

Show Affiliations

1. Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Neurological Sciences Published:2023

Abstract

Our registry-based cross-sectional study covered 27,508 PwMS in Tehran with a point incidence rate and prevalence of 7.87 and 194.62 per 100,000 in 2021, respectively. We found that the incidence and prevalence of MS in Tehran are still on an upward trend which requires general attention and measures to overcome. The proportion of men with a family history of MS was significantly higher. Whilst IMSS deals with economic difficulties, it continues to collect new PwMS to reach regional-level coverage in Tehran for better MS care services. © 2023, Fondazione Societa Italiana di Neurologia.

Related Docs

View other Related Docs

1. Consanguineous Marriage Among Familial Multiple Sclerosis Subjects: A National Registry-Based Study, Heliyon (2024)

2. Investigation of Pregnancy Tendency, Reproductive Characteristics, and Disability in Women With Multiple Sclerosis: A Secondary Data Analysis of the National Registry in Iran, Current Journal of Neurology (2024)

3. Economic and Social Standing of Individuals in Iran Diagnosed With Multiple Sclerosis, Archives of Iranian Medicine (2023)

4. A National Registry-Based Study of Ethnic Differences in People With Multiple Sclerosis in Iran, Clinical Neurology and Neurosurgery (2024)

5. Time Interval Between the Onset of Symptoms and Diagnosis of Multiple Sclerosis and the Influential Factors: A National Registry-Based Study, Clinical Neurology and Neurosurgery (2024)

6. Lifetime Exposure to Smoking and Substance Abuse May Be Associated With Late-Onset Multiple Sclerosis: A Population-Based Case-Control Study, BMC Neurology (2024)

7. Epidemiology of Familial Multiple Sclerosis in Iran: A National Registry-Based Study, BMC Neurology (2022)

8. Prevalence of Multiple Sclerosis and Its Risks in Tehran, Iran, in 2019, Neurological Sciences (2021)

Experts (# of related papers)

View all Related Experts

Sharareh Eskandarieh (13)

Mohammad Ali Sahraian (13)

Style	Citing Format
MLA	Ezabadi SG, et al.. "The Incidence and Prevalence of Crude and Familial Multiple Sclerosis in Tehran, Iran in 2021." Neurological Sciences, vol. 44, no. 12, 2023, pp. 4517-4518.
APA	Ezabadi SG, Ayoubi S, Sahraian MA, Omrani MA, Eskandarieh S (2023). The Incidence and Prevalence of Crude and Familial Multiple Sclerosis in Tehran, Iran in 2021. Neurological Sciences, 44(12), 4517-4518.
Chicago	Ezabadi SG, Ayoubi S, Sahraian MA, Omrani MA, Eskandarieh S. "The Incidence and Prevalence of Crude and Familial Multiple Sclerosis in Tehran, Iran in 2021." Neurological Sciences 44, no. 12 (2023): 4517-4518.
Harvard	Ezabadi SG et al. (2023) 'The Incidence and Prevalence of Crude and Familial Multiple Sclerosis in Tehran, Iran in 2021', Neurological Sciences, 44(12), pp. 4517-4518.
Vancouver	Ezabadi SG, Ayoubi S, Sahraian MA, Omrani MA, Eskandarieh S. The Incidence and Prevalence of Crude and Familial Multiple Sclerosis in Tehran, Iran in 2021. Neurological Sciences. 2023;44(12):4517-4518.
BibTex	@article{ author = {Ezabadi SG and Ayoubi S and Sahraian MA and Omrani MA and Eskandarieh S}, title = {The Incidence and Prevalence of Crude and Familial Multiple Sclerosis in Tehran, Iran in 2021}, journal = {Neurological Sciences}, volume = {44}, number = {12}, pages = {4517-4518}, year = {2023} }
RIS	TY - JOUR AU - Ezabadi SG AU - Ayoubi S AU - Sahraian MA AU - Omrani MA AU - Eskandarieh S TI - The Incidence and Prevalence of Crude and Familial Multiple Sclerosis in Tehran, Iran in 2021 JO - Neurological Sciences VL - 44 IS - 12 SP - 4517 EP - 4518 PY - 2023 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract